Dr. Dannenberg on Inflammation and Increased Breast Cancer Risk

Andrew Dannenberg, MD
Published: Thursday, May 07, 2015



Andrew Dannenberg, MD, professor of Medicine, Weill Cornell Medical College, discusses the association between breast inflammation and breast cancer.  In a study looking at women with metastatic breast cancer, long-term distant recurrence-free survival was reduced in those who had white adipose or occult inflammation compared to those who did not.  

Although white adipose inflammation of the breast has previously been associated with elevated body mass index (BMI), Dannenberg reported that approximately one-third of normal BMI women have breast inflammation. This inflammation is believed to contribute to insulin resistance, which is associated with an increased risk of breast cancer among those with a normal BMI.  

This means that many women at a healthy weight may have an unrecognized risk factor for breast cancer.

SELECTED
LANGUAGE


Andrew Dannenberg, MD, professor of Medicine, Weill Cornell Medical College, discusses the association between breast inflammation and breast cancer.  In a study looking at women with metastatic breast cancer, long-term distant recurrence-free survival was reduced in those who had white adipose or occult inflammation compared to those who did not.  

Although white adipose inflammation of the breast has previously been associated with elevated body mass index (BMI), Dannenberg reported that approximately one-third of normal BMI women have breast inflammation. This inflammation is believed to contribute to insulin resistance, which is associated with an increased risk of breast cancer among those with a normal BMI.  

This means that many women at a healthy weight may have an unrecognized risk factor for breast cancer.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication
x